DRGEM Announces Q1 Results: 17% Revenue Increase and 10% Operating Margin

– Driven by an increase in overseas orders and strong sales of General DR

– Accelerating the global shift to digital medical imaging… Strengthening growth momentum

■ Q1 2026 Financial Performance Overview

DRGEM, a global medical imaging solutions company, achieved both double-digit revenue growth and improved profitability in the first quarter of this year. This was driven by the growth of the global digital X-ray market.

DRGEM announced that it recorded consolidated revenue of 27.3 billion won and operating income of 2.7 billion won for the first quarter of 2026. Revenue increased by approximately 17% year-over-year. At the same time, operating income rose by approximately 50.3%. The operating margin stood at 10%. This is up 2.2 percentage points from the same period last year.

DRGEM explained that despite global economic uncertainty and geopolitical risks in the Middle East, the growth of the digital radiography (DR) market and stable sales of its flagship General DR products drove the improvement in performance. In addition, an increase in orders, particularly from overseas markets, also contributed to the growth trend.

By business segment, General DR accounted for 78.4% of total revenue and led revenue growth. Mobile DR accounted for 7.0%, while sales of other products and components accounted for 14.6%. The company stated that the expansion of orders in overseas markets, along with increased sales of components and other products, had a positive impact on profitability.

■ Global Market Outlook and Portfolio Expansion

DRGEM maintains a stable order backlog in its existing core markets, including North America, Europe, and the Middle East. At the same time, the company forecasts that robust sales growth will continue in the future as demand for the transition to digital X-ray increases. This is particularly true in South America and Africa.

DRGEM is expanding its business portfolio to include digital imaging software and ultrasound systems, in addition to fixed and mobile digital X-ray systems. DRGEM’s strategy is to strengthen its position as a digital medical imaging solutions provider. The company is moving beyond the simple supply of equipment by leveraging the competitiveness of its proprietary imaging software.

J. B. Park, CEO of DRGEM, stated, “Amid the continued expansion of demand for digital transformation in the global medical imaging market, we are maintaining stable growth based on the competitiveness of our core DR business.” He added, “We plan to secure a foundation for sustainable growth by expanding our global market presence and enhancing product competitiveness.”